B-type natriuretic peptide (BNP) and N-terminal B-type natriuretic peptide precursor (NT-proBNP) are biomarkers of cardiac function, as well as the preferred biomarkers for the diagnosis and differential diagnosis of heart failure, disease severity and prognosis assessment, and have been recommended as Level I by several clinical practice guidelines. BNP is mainly degraded in large blood ves...
In vitro diagnostic reagent stability refers to the ability of an in vitro diagnostic medical device to maintain its performance characteristics within the limits specified by the manufacturer, reflecting the product's ability to grow with In the process of storage, transportation and use of in vitro diagnostic reagents, various influencing factors such as temperature, humidity, light, repe...
Infectious diseases are one of the common diseases in the emergency department, and the systemic inflammatory response syndrome caused by infection is the most fundamental pathophysiological change in sepsis. Due to the complexity of the systemic inflammatory response, there are no ideal diagnostic, stratification, prognostic tools, and effective treatment options. A number of studies have demonst...
Major risk factors for cardiovascular disease Hypertension: one of the main controllable risk factors, accounting for 50% of cardiovascular disease morbidity and 20% of deaths, but the awareness rate is only 46.9%, and the blood pressure control rate is even lower to 15.3%. Dyslipidemia: Studies have shown that the awareness, treatment and control rates of dyslipidemia in ≥ 18-year-olds need to...
World Stroke Day is observed on October 29 to underscore the serious nature and high rates of stroke, raise awareness of the prevention and treatment of the condition, and ensure better care and support for survivors. Stroke and platelet function Stroke refers to an acute cerebrovascular disease caused by the sudden rupture of blood vessels in the brain or the sudden interruption of blood flo...
Introduction: In the rapidly evolving field of diagnostics, advanced technologies are paving the way for faster, more accurate, and convenient testing solutions. As a leading manufacturer and exporter of dry-chemistry chemiluminescence immunoassay analyzers and assay kits, we are proud to introduce a breakthrough solution that addresses the key challenges in diagnostic testing. Our cutting-edge pl...
In the world of diagnostic assays, the advancements in chemiluminescence technology have sparked a revolution. As a leading manufacturer and exporter of dry chemiluminescence immunoassay analyzers and a wide range of test kits, Poclight Biotechnology are proud to introduce the fifth generation chemiluminescence platelet activation testing, which has taken the medical community by storm. With its u...
In the fast-evolving landscape of healthcare, Point-of-Care Testing (POCT) has emerged as a game-changer. This innovative approach allows healthcare providers to conduct tests at or near the site of patient care, leading to quicker diagnosis and treatment. One of the standout advantages of POCT is its ability to streamline processes, offering numerous benefits that enhance patient care and operati...